Cervical Cancer in the Baltic States: Can Intelligent and Personalized Cancer Screening Change the Situation?

Q3 Medicine Acta Medica Lituanica Pub Date : 2022-01-01 Epub Date: 2022-06-29 DOI:10.15388/Amed.2022.29.1.18
Mindaugas Stankūnas, Kersti Pärna, Anna Tisler, Anda Ķīvīte-Urtāne, Una Kojalo, Jana Zodzika, Nicholas Baltzer, Jan Nygard, Mari Nygard, Anneli Uuskula
{"title":"Cervical Cancer in the Baltic States: Can Intelligent and Personalized Cancer Screening Change the Situation?","authors":"Mindaugas Stankūnas,&nbsp;Kersti Pärna,&nbsp;Anna Tisler,&nbsp;Anda Ķīvīte-Urtāne,&nbsp;Una Kojalo,&nbsp;Jana Zodzika,&nbsp;Nicholas Baltzer,&nbsp;Jan Nygard,&nbsp;Mari Nygard,&nbsp;Anneli Uuskula","doi":"10.15388/Amed.2022.29.1.18","DOIUrl":null,"url":null,"abstract":"<p><p>The three Baltic States (Estonia, Latvia, and Lithuania) are among the European Union countries with the highest incidence and mortality rates for cervical cancer. In order to tackle this public health challenge, there is an urgent need to implement more advanced and effective methods in cervical cancer prevention in Baltic countries. Nationwide cervical cancer screening programs in the Baltic States commenced in 2004-2009. While the organized screening programs in these countries differ in some relevant details (target age groups, screening interval), the underlying principles and problems, barriers are universal. However, the outcomes of present screening programs are unsatisfactory. In addition, universal screening programs are extremely costly. There is a potential need for more intelligent and personalized cervical cancer screening program. In 2019 the project <i>\"Towards elimination of cervical cancer: intelligent and personalized solutions for cancer screening\"</i> (2020-2023) was developed with the main objective - to develop improved and personalized cancer screening methods within a sustainable health care system. It is expected, that more sophisticated cervical cancer screening model will be implemented in Estonia, Latvia, and Lithuania, and will have a positive impact to epidemiology of cervical cancer and public health in general.</p>","PeriodicalId":34365,"journal":{"name":"Acta Medica Lituanica","volume":"29 1","pages":"19-26"},"PeriodicalIF":0.0000,"publicationDate":"2022-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9428648/pdf/","citationCount":"3","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Acta Medica Lituanica","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.15388/Amed.2022.29.1.18","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"2022/6/29 0:00:00","PubModel":"Epub","JCR":"Q3","JCRName":"Medicine","Score":null,"Total":0}
引用次数: 3

Abstract

The three Baltic States (Estonia, Latvia, and Lithuania) are among the European Union countries with the highest incidence and mortality rates for cervical cancer. In order to tackle this public health challenge, there is an urgent need to implement more advanced and effective methods in cervical cancer prevention in Baltic countries. Nationwide cervical cancer screening programs in the Baltic States commenced in 2004-2009. While the organized screening programs in these countries differ in some relevant details (target age groups, screening interval), the underlying principles and problems, barriers are universal. However, the outcomes of present screening programs are unsatisfactory. In addition, universal screening programs are extremely costly. There is a potential need for more intelligent and personalized cervical cancer screening program. In 2019 the project "Towards elimination of cervical cancer: intelligent and personalized solutions for cancer screening" (2020-2023) was developed with the main objective - to develop improved and personalized cancer screening methods within a sustainable health care system. It is expected, that more sophisticated cervical cancer screening model will be implemented in Estonia, Latvia, and Lithuania, and will have a positive impact to epidemiology of cervical cancer and public health in general.

查看原文
分享 分享
微信好友 朋友圈 QQ好友 复制链接
本刊更多论文
波罗的海国家的宫颈癌:智能和个性化的癌症筛查能改变这种状况吗?
波罗的海三国(爱沙尼亚、拉脱维亚和立陶宛)是宫颈癌发病率和死亡率最高的欧洲联盟国家之一。为了应对这一公共卫生挑战,波罗的海国家迫切需要在预防宫颈癌方面采用更先进和更有效的方法。2004-2009年,波罗的海国家启动了全国范围的宫颈癌筛查方案。虽然这些国家有组织的筛查计划在一些相关细节(目标年龄组、筛查间隔)上有所不同,但基本原则和问题、障碍是普遍存在的。然而,目前的筛查方案的结果并不令人满意。此外,普遍筛查项目非常昂贵。有一个潜在的需求,更智能和个性化的宫颈癌筛查计划。2019年,制定了“迈向消除宫颈癌:智能和个性化癌症筛查解决方案”(2020-2023年)项目,其主要目标是在可持续的医疗保健系统内开发改进的个性化癌症筛查方法。预计将在爱沙尼亚、拉脱维亚和立陶宛实施更先进的宫颈癌筛查模式,并将对宫颈癌流行病学和一般公共卫生产生积极影响。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 去求助
来源期刊
Acta Medica Lituanica
Acta Medica Lituanica Medicine-General Medicine
CiteScore
0.70
自引率
0.00%
发文量
33
审稿时长
16 weeks
期刊最新文献
Successful Endovascular Management of Recurrent Hemoptysis due to Multiple Rasmussen Aneurysms in a Case of Pulmonary Tuberculosis: A Rare Case Scenario Knee Extensor Apparatus Reconstruction with Allograft after Patellar Resection: A Case Report Accidental Intravenous Administration of Simethicone in a 4-Year-Old Patient: A Case Report Evaluation of Blood Culture Results in Patients with Malignancy in Erzurum Province, Turkey Prediction of Poor Outcome Using the Urea to Albumin Ratio in Thoracic Empyema
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
已复制链接
已复制链接
快去分享给好友吧!
我知道了
×
扫码分享
扫码分享
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1